A new practice: Study on the molecular mechanism of traditional chinese medicine by computational pharmacology methods: Part 2: Pharmacodynamic modeling and distribution on ligand-target space of effective components

Letters in Drug Design and Discovery

Volumn 8, Issue 10, 2011, Pages 1009-1014

  Wu, Ding Hong ^a   Xu, Xiao Jie ^a,b   Zhang, Min Zhou ^a   Wang, Lei ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Drug target Network; Ligand target Space; Pharmacodynamic(PD) Modeling; Traditional Chinese Medicine

Indexed keywords

CHINESE DRUG; TONGGUAN CAPSULE; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CHEMICAL COMPOSITION; CHINESE MEDICINE; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SCREENING; ISCHEMIC HEART DISEASE; MOLECULAR DOCKING; MOLECULAR MODEL; PHARMACODYNAMICS; PRIORITY JOURNAL;

EID: 80655146195     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018011797655331     Document Type: Article

References (30)

1. Xu, X. New concepts and approaches for drug discovery based on traditional Chinese medicine. Drug Discovery Today:Technologies, 2006, 3, 247-253. (Pubitemid 44734730)
2. Li, S. Network systems underlying traditional Chinese medicine syndrome and herb formula. Current Bioinformatics, 2009, 4, 188-196.
3. Morphy, R.; Kay, C.Rankovic, Z. From magic bullets to designed multiple ligands. Drug Discov Today, 2004, 9, 641-651. (Pubitemid 38981718)
4. Mayer, J.; Zackova, D.; Klamova, H.Doubek, M. Therapy of chronic myeloid leukemia. Uncommon view of the modern approaches. Cas Lek Cesk, 2008, 147, 206-210.
5. Barabasi, A.L.; Gulbahce, N.Loscalzo, J. Network medicine: a network-based approach to human disease. Nat Rev Genet, 2011, 12, 56-68.
6. Hopkins, A.L. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol, 2008, 4, 682-690.
7. Kitano, H. Computational systems biology. Nature, 2002, 420, 206-210. (Pubitemid 35340131)
8. Kleemann, R.; Bureeva, S.; Perlina, A.; Kaput, J.; Verschuren, L.; Wielinga, P.; Hurt-Camejo, E.; Nikolsky, Y.; van Ommen, B.Kooistra, T. A Systems Biology Strategy for Predicting Similarities and Differences of Drug Effects: Evidence for Drug- specific Modulation of Inflammation in Atherosclerosis. BMC systems biology, 2011, 5, 125.
9. Stephenson, V.C.; Heyding, R.A.Weaver, D.F. The "promiscuous drug concept" with applications to Alzheimer's disease. FEBS Lett, 2005, 579, 1338-1342. (Pubitemid 40289177)
10. Guzecka-Ruszczynska, E.Czarnecki, A. [Multi-component preparations in present-day drug therapy]. Pol Tyg Lek, 1992, 47, 274-277.
11. Xu, X.J. study on computer simulation for chinese traditional compound medicine. Progress in chemistry 1999 ;11: 202-204.
12. Wu, D.H.Xu, X.J. A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 1: Pharmacokinetic Modeling and Chemical Space Distribution. Letters in Drug Design & Discovery, 2011, 8, 652-658.
13. Kauvar, L.M.; Higgins, D.L.; Villar, H.O.; Sportsman, J.R.; Engqvist-Goldstein, A.; Bukar, R.; Bauer, K.E.; Dilley, H.Rocke, D.M. Predicting ligand binding to proteins by affinity fingerprinting. Chem Biol, 1995, 2, 107-118.
14. Yildirim, M.A.; Goh, K.I.; Cusick, M.E.; Barabasi, A.L.Vidal, M. Drug-target network Nat Biotechnol, 2007, 25, 1119-1126. (Pubitemid 47538114)
15. Taal, M.W.Brenner, B.M. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int, 2000, 57, 1803-1819.
16. Choi, K.C.; Ryu, O.H.; Lee, K.W.; Kim, H.Y.; Seo, J.A.; Kim, S.G.; Kim, N.H.; Choi, D.S.; Baik, S.H.Choi, K.M. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Biochem Biophys Res Commun, 2005, 336, 747-753. (Pubitemid 41338332)
17. Gu, Q.; Yang, X.P.; Bonde, P.; Di Paula, A.; Fox-Talbot, K.Becker, L.C. Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog. J Cardiovasc Pharmacol, 2006, 48, 320-327.
18. Alvarez S.M.; Vega, S.; Mingorance, C.; Marhuenda, E.Herrera, M.D. Effects of HMG-Co A Reductase Inhibition by Simvastatin on Vascular Dysfunction Induced by Lipopolysaccharide in Rats. Pharmacology, 2008, 82, 89-96.
19. Claudel, T.; Sturm, E.; Duez, H.; Torra, I.P.; Sirvent, A.; Kosykh, V.; Fruchart, J.C.; Dallongeville, J.; Hum, D.W.; Kuipers, F.Staels, B. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J Clin Invest, 2002, 109, 961-971. (Pubitemid 34275117)
20. Mackman, N.; Tilley, R.E.Key, N.S. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol, 2007, 27, 1687-1693. (Pubitemid 47207163)
21. Gailani, D.Renne, T. The intrinsic pathway of coagulation: a target for treating thromboembolic disease? J Thromb Haemost, 2007, 5, 1106-1112. (Pubitemid 46902107)
22. Bioinformatics and drug design group. Therapeutic targets database. http://xin.cz3.nus.edu.sg/group/cjttd/ttd.asp.
23. Protein Data Bank. An Information Portal to Biological Macromolecular Structures. http://www.rcsb.org/pdb/home/home.do.
24. Networks/Pajek. Program for Large Network Analysis. http://vlado.fmfuni- lj.si/pub/networks/pajek/default.htm (Replaced January 2008).
25. Wuchty, S.P.F., S. Centers of complex networks. J Theor Biol, 2003, 223, 45-53
26. Centralities in Biological Networks. http://centibin.ipk- gatersleben.de/.
27. Zhao, X.Zhang, M. Tongguan capsule has effect on blood-lipid level and plasma concentration of inflammatory cytokines of the high fat rats. Chinese journal of intergrative medicine on cardio- /cerebro vascular disease, 2007, 5, 951-952.
28. Ge, Z.; Zhang, M.; Chen, B.; Wang, D.; Zhou, D.; Bin, D.Li, Y. Tongguang capsule had effected on coagulation-fibrilysis system of unstabe angina pectoris patients. New Medicine, 2010, 41, 794-796.
29. Kunz, R. "What's in the black box?". Chest, 2006, 129, 7-10. (Pubitemid 43265236)
30. Arteaga, C.L. Molecular therapeutics: is one promiscuous drug against multiple targets better than combinations of molecule- specific drugs? Clin Cancer Res, 2003, 9, 1231-1232. (Pubitemid 36418369)